Follow us on twitter Follow us on X

Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) – published online 24/09/2022

Melanie J. Davies, Vanita R. Aroda, Billy S. Collins, Robert A. Gabbay, Jennifer Green, Nisa M. Maruthur, Sylvia E. Rosas, Stefano Del Prato, Chantal Mathieu, Geltrude Mingrone, Peter Rossing, Tsvetalina Tankova, Apostolos Tsapas, John B. Buse

In 2022, the ADA/EASD updated their consensus report on the management of hyperglycaemia in type 2 diabetes. In this issue, Davies et al ( present important changes to the 2019 consensus, reflecting new evidence generated in the last 3 years, such as that from cardiovascular and renal outcome trials of sodium–glucose cotransporter-1 inhibitors and glucagon-like peptide-1 receptor agonists, including assessment of subgroups. Recommendations for cardiorenal protection in those with diabetes and at high risk of cardiorenal disease are also presented. The authors focus on holistic management, weight management and consideration of physical behaviours, including sleep, over a 24 h period. The authors also outline that social determinants of health must be addressed if we are to aspire to improve health outcomes. The consensus concludes with a ‘Call to Action’ stating that we must establish and refine quality improvement efforts in diabetes care at local level to equitably implement evidence-based interventions for the benefit of all people living with type 2 diabetes.

All News